Parameters for calcium metabolism in
women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study.
Not exact matches
For example
women who suffer
with PCOS,
polycystic ovary syndrome, in some cases have a delay on the state of lactation so they may struggle to make enough milk in the first week or so after giving birth.
Women who have polycystic ovary syndrome (PCOS), a common hormone condition that contributes to infertility and metabolic problems, such as diabetes and heart disease, tend to have less diverse gut bacteria than women who do not have the condition, according to researchers at University of California San Diego School of Medicine, in collaboration with colleagues at Poznan University of Medical Sciences in Poland and San Diego State Univer
Women who have
polycystic ovary syndrome (PCOS), a common hormone condition that contributes to infertility and metabolic problems, such as diabetes and heart disease, tend to have less diverse gut bacteria than
women who do not have the condition, according to researchers at University of California San Diego School of Medicine, in collaboration with colleagues at Poznan University of Medical Sciences in Poland and San Diego State Univer
women who do not have the condition, according to researchers at University of California San Diego School of Medicine, in collaboration
with colleagues at Poznan University of Medical Sciences in Poland and San Diego State University.
Soon - to - be moms should take precaution: a new study revealed that
women with polycystic ovary syndrome (PCOS) are more likely to bear children
who are at risk for developing autism spectrum disorders (ASD).
Birth control pills have long been demonstrated as a first - line treatment option for
women with Polycystic Ovary Syndrome (PCOS)
who suffer from painful or irregular or absent periods.Some
women may take Oral contraceptive pills (OCPs) to help lower androgen levels and improve unwanted dermatological symptoms.
Testing should be considered for all individuals
who are overweight or obese (BMI 25 or greater) plus the additional risks: first degree relative
with diabetes mellitus or
Polycystic Ovarian Disease, history of gestational diabetes, thyroid disorder, HDL level < 35 mg / dl and / or Triglyceride level > 250 mg / dl, hypertensive, sedentary, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous testing, women who delivered macrosomic baby (e.g. weighing > 9 lbs), and other clinical conditions such as acanthosis nigricans, severe obesity, polycystic ovary syndrome, dys
Polycystic Ovarian Disease, history of gestational diabetes, thyroid disorder, HDL level < 35 mg / dl and / or Triglyceride level > 250 mg / dl, hypertensive, sedentary, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous testing,
women who delivered macrosomic baby (e.g. weighing > 9 lbs), and other clinical conditions such as acanthosis nigricans, severe obesity,
polycystic ovary syndrome, dys
polycystic ovary syndrome, dyslipidemia.
Improve fertility in
women who are obese, especially
women with polycystic ovary syndrome (PCOS).